Jynarque 90MG-30MG
Ended Awarded
- Contract number
- 36C24525N0428
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $13,168
Award facts
- Contract value 100% obligated
- $13,168.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. received a $13,168.39 firm fixed price delivery order from the Department of Veterans Affairs' Veterans Integrated Service Network 5 on March 5, 2025, with an ultimate completion date of March 7, 2025. The award covers Jynarque 90MG-30MG, a specialty pharmaceutical product used to treat autosomal dominant polycystic kidney disease and hyponatremia. This delivery order was issued without a set-aside designation and is performed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with services to be delivered to Pittsburgh, Pennsylvania.
This delivery order is issued against Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement valued at $83.3 million for Jynarque, which was awarded by the VA's National Acquisition Center and extends through March 26, 2026. The BPA enables VA facilities across multiple Integrated Service Networks to efficiently procure this critical medication. As a major pharmaceutical supplier to the VA's Veterans Health Administration, Otsuka America Pharmaceutical Inc. maintains significant federal supply schedule contracts totaling approximately $396 million, reflecting its established capability to deliver specialized pharmaceutical treatments to support the VA's healthcare mission for veterans nationwide.
Quick answers
Who was awarded contract 36C24525N0428?
36C24525N0428 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 5, 2025.
How much is contract 36C24525N0428 worth?
The government has obligated $13,168 on 36C24525N0428.
Is contract 36C24525N0428 an order under another contract?
Yes. 36C24525N0428 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0428 competed?
The extent of competition for 36C24525N0428 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award